Org-10490 is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key compound in the development of novel therapeutic agents, particularly in the treatment of neurological disorders. Its unique structure allows it to interact with specific receptors in the brain, making it a promising candidate for targeting conditions such as anxiety, depression, and chronic pain. Researchers are also exploring its potential in modulating neurotransmitter activity, which could lead to breakthroughs in managing neurodegenerative diseases like Alzheimer's and Parkinson's. Additionally, Org-10490 is being studied for its role in enhancing cognitive functions and memory retention, offering potential applications in cognitive enhancement therapies. Its versatility and efficacy in preclinical studies have made it a valuable tool for advancing drug discovery and development processes.